Ray, Arghya http://orcid.org/0000-0002-0652-2905
Du, Ting
Wan, Xueping
Song, Yan http://orcid.org/0000-0002-6729-2672
Pillai, Sindhu C.
Musa, Md. Abu http://orcid.org/0000-0003-0662-0078
Fang, Teng
Moore, Jared
Blank, Brian
Du, Xiaohui
Chen, Xi
Warne, Robert
Sutimantanapi, Dena
Lui, Fang
Zavorotinskaya, Tatiana
Colas, Christophe
Friedman, Lori
Junttila, Melissa R.
Chauhan, Dharminder http://orcid.org/0000-0002-5548-6138
Anderson, Kenneth C. http://orcid.org/0000-0002-6418-0886
Article History
Received: 22 November 2023
Revised: 19 February 2024
Accepted: 20 February 2024
First Online: 9 April 2024
Competing interests
: KCA is an advisor for Janssen, Pfizer and AstraZeneca; and has ownership interests in C4 Therapeutics, Dynamic Cell Therapies, Window Therapeutics, Starton Therapeutics, NextRNA and OncoPep. DC is Equity owner in C4 Therapeutics. AR, TD, XW, YS, SCP, Md. AM, and TF have no competing financial interests JM, BB, XD, CC, RW, DS, TZ, LF and MRJ are employees and equity owners of ORIC Pharmaceuticals, Inc.